This profound response of tumors exhibiting high genomic instability may be partially explained by excessive production and release of peptide neoantigens that favor the recruitment or activation of tumor-infiltrating lymphocytes (TILs) and result in up-regulation of PD-1/PD-L1 in immune and cancer cells [114]. Here, PDCD1 is linked to cancer.